---
title: "Methylprednisolone Acetate Injection Shortage: Current Availability and Manufacturer Updates"
summary: "The FDA reports an ongoing shortage of Methylprednisolone Acetate Injection, a medication used in rheumatology, with supply levels varying significantly across major manufacturers."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Methylprednisolone Acetate","Injection"]
location: "United States"
severity: "medium"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T14:39:03.000Z
---
### What's in Shortage
Methylprednisolone Acetate Injection, a medication primarily used within the therapeutic category of rheumatology, is currently listed as being in shortage. The shortage affects multiple strengths, specifically the 40 mg/1 mL and 80 mg/1 mL presentations. This shortage status was first posted on December 15, 2021, and was most recently updated on February 9, 2026.

### Which Manufacturers Are Affected
Several manufacturers are currently experiencing supply issues, while others maintain limited or full inventory:

*   **Amneal Pharmaceuticals (866-525-7270):** 
    *   80 mg/1 mL (NDC 70121-1574-5): Available; 2 to 4 weeks of inventory based on demand. Next supply expected week of February 9, 2026.
    *   80 mg/1 mL (NDC 70121-1574-1): Available; 4 to 8 weeks of inventory. Next supply expected week of March 16, 2026.
    *   40 mg/1 mL (NDC 70121-1573-5): Available, but currently under backorder due to demand. Next supply expected week of February 9, 2026.
    *   40 mg/1 mL (NDC 70121-1573-1): Limited Availability; 4 to 6 weeks of inventory. Next supply expected week of February 9, 2026.
*   **Sagent Pharmaceuticals (866-625-1618):** 
    *   40 mg/1 mL (NDC 25021-820-10) and 80 mg/1 mL (NDC 25021-821-05): Available.
    *   40 mg/1 mL (NDC 25021-820-05): Limited Availability; estimated availability May 2026.
*   **Eugia US LLC (888-238-7880):** 
    *   40 mg/1 mL and 80 mg/1 mL: Unavailable. Currently on backorder with a recovery date to be determined. Patients and providers are advised to check wholesalers for inventory.
*   **Par Health, USA LLC (800-828-9393):** 
    *   80 mg/1 mL (NDC 42023-240-01): Unavailable.

### Why There's a Shortage
The source data does not provide a specific underlying cause for the shortage, though some manufacturers note that current inventory levels are being impacted by high demand.

### What Patients Should Do
If you rely on Methylprednisolone Acetate Injection for your treatment, please consider the following steps:
*   **Consult Your Healthcare Provider:** Speak with your doctor regarding your treatment plan and potential alternatives if your specific dosage is unavailable. 
*   **Speak with Your Pharmacist:** Pharmacists may have information on local stock or may be able to source the medication from different wholesalers.
*   **Contact Manufacturers:** You may use the contact information provided above to inquire about the most recent availability updates for specific NDCs.

**Disclaimer:** Patients should always consult with their healthcare provider or pharmacist for medical advice and before making any changes to their medication regimen.

### Source
Information provided by the FDA Drug Shortage Database.